Page 39 - Read Online
P. 39

Plössl et al. J Transl Genet Genom 2022;6:46-62  https://dx.doi.org/10.20517/jtgg.2021.39  Page 52

               Table 1. Characteristics of chromosomal loci used for genotyping and AMD-associated GRS calculations
                ID Locus         SNP        Impact/effect of variant  Odds ratio  Non risk allele  Risk allele
                1  CFH           rs1061170  p.Y402H                   2.74       T              C
                2                rs800292   p.I62V                    2.43       A              G
                3                rs6677604  Proxy for  CFHR3/CFHR1    2.19       A              G
                4  ARMS2/HTRA1   rs10490924  p.A69S                   3.13       G              T
                5  CFB           rs4151667  p.L9H                     2.82       A              T
                6                rs438999   proxy for rs641153 (p.R32Q)  2.31    C              T
                7  C3            rs2230199  p.R102G                   1.52       G              C
                8  APOE          rs7412     p.R158C                   1.41       C              T
                9                rs429358   p.C112R                   1.35       C              T
                10  PLA2G12A     rs2285714  Synonymous exonic, unknown  1.14     C              T
                11  LIPC         rs493258   Intergenic (36 kb upstream)  1.18    T              C
                12               rs10468017  Intergenic (46 kb upstream)  1.26   T              C
                13  TIMP3        rs9621532  Intronic, unknown         1.58       C              A

               AMD: Age-related macular degeneration; GRS: genetic risk score.


               Table 2. Characteristics of iPSC-RPE lines generated
                                                            Homozygosity for risk                        #
                Cell line Source  Gender YOB AMD status Affected eye  allele of SNP ID #  Heterozygosity for risk allele SNP ID
                HR1   Fibroblast M  1947 CNV     L          1, 2, 3, 4, 5, 6, 9, 10, 12, 13  11
                HR2   PBMC   F     1950 CNV      L/R        1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 13  11, 12
                HR3   PBMC   F     1950 CNV      L/R        1, 2, 3, 4, 5, 6, 9, 10, 11, 12, 13
                HR4   Fibroblast F  1946 CNV     L/R        1, 2, 3, 4, 5, 6, 9, 10, 12, 13  11
                LR1   PBMC   M     1924 Control  -          5, 6, 9, 13       2, 3, 11, 12
                LR2   PBMC   M     1946 Control  -          3, 6, 9, 10, 13   2, 5, 8, 12
                LR3   PBMC   F     1933 Control  -          2, 9, 13          3, 5, 6, 10, 12
                LR4   Fibroblast F  1928 Control  -         3, 5, 9, 10, 13   2, 6, 12

               Numbers 1-13 were assigned to the AMD-associated SNPs listed in Table 1. SNP: Single nucleotide polymorphism; iPSC: induced pluripotent stem
               cell; RPE: retinal pigment epithelium; HR: High risk; LR: low risk; PBMC: peripheral blood mononuclear cells; M: male; F: female; CNV: choroidal
               neovascularization; YOB: year of birth; L: left; R: right.

               high quality of the established iPSC-RPE cell lines with a defined genetic AMD risk profile. Regarding RPE
               properties, cell lines from different genetic backgrounds display no major differences providing a solid
               model for addressing the molecular pathobiology of AMD.

               Establishing an oxidative stress model to mimic environmental risk factors in vitro
               One of our aims is to delineate molecular processes differentiating between HR and LR iPSC-RPE lines. In a
               first step, we tested expression of complement genes CFH and C3 as well as NRF2 signaling response genes
               HMOX1 and NQO1. Data from four individual batches of cells cultured independently (with three technical
               replicates per batch) were included. Data from qRT-PCR were normalized against HPRT1 expression and
               calibrated against the mean of all low-risk cell lines. The results reveal no significant differences, which in
               part could be due to a high variability in baseline expression between the individual cell lines [Figure 3A].
   34   35   36   37   38   39   40   41   42   43   44